Nishime JA[au] - Search Results

Year	Number of Results
1995	2
1996	3
1997	1
1998	1
1999	2
2000	2
2023	0

1

Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.

Lin JH, Chiba M, Chen IW, Nishime JA, Vastag KJ. Lin JH, et al. Among authors: nishime ja. Drug Metab Dispos. 1996 Dec;24(12):1298-306. Drug Metab Dispos. 1996. PMID: 8971134

2

Route-dependent nonlinear pharmacokinetics of a novel HIV protease inhibitor: involvement of enzyme inactivation.

Lin JH, Chen IW, Chiba M, Nishime JA, Deluna FA. Lin JH, et al. Among authors: nishime ja. Drug Metab Dispos. 2000 Apr;28(4):460-6. Drug Metab Dispos. 2000. PMID: 10725315

3

Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes.

Chiba M, Nishime JA, Chen IW, Vastag KJ, Sahly YS, Kim BM, Dorsey BD, Vacca JP, Lin JH. Chiba M, et al. Among authors: nishime ja. Biochem Pharmacol. 1998 Jul 15;56(2):223-30. doi: 10.1016/s0006-2952(98)00139-7. Biochem Pharmacol. 1998. PMID: 9698076

4

Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans.

Chiba M, Xu X, Nishime JA, Balani SK, Lin JH. Chiba M, et al. Among authors: nishime ja. Drug Metab Dispos. 1997 Sep;25(9):1022-31. Drug Metab Dispos. 1997. PMID: 9311616

5

Comparative in vitro metabolism of indinavir in primates--a unique stereoselective hydroxylation in monkey.

Chiba M, Nishime JA, Neway W, Lin Y, Lin JH. Chiba M, et al. Among authors: nishime ja. Xenobiotica. 2000 Feb;30(2):117-29. doi: 10.1080/004982500237721. Xenobiotica. 2000. PMID: 10718120

6

Time- and dose-dependent pharmacokinetics of L-754,394, an HIV protease inhibitor, in rats, dogs and monkeys.

Lin JH, Chiba M, Chen IW, Vastag KJ, Nishime JA, Dorsey BD, Michelson SR, McDaniel SL. Lin JH, et al. Among authors: nishime ja. J Pharmacol Exp Ther. 1995 Jul;274(1):264-9. J Pharmacol Exp Ther. 1995. PMID: 7616407

7

Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.

Chiba M, Hensleigh M, Nishime JA, Balani SK, Lin JH. Chiba M, et al. Among authors: nishime ja. Drug Metab Dispos. 1996 Mar;24(3):307-14. Drug Metab Dispos. 1996. PMID: 8820421

8

Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction.

Lin JH, Chiba M, Chen IW, Nishime JA, deLuna FA, Yamazaki M, Lin YJ. Lin JH, et al. Among authors: nishime ja. Drug Metab Dispos. 1999 Oct;27(10):1187-93. Drug Metab Dispos. 1999. PMID: 10497146

9

Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor.

Chiba M, Nishime JA, Lin JH. Chiba M, et al. Among authors: nishime ja. J Pharmacol Exp Ther. 1995 Dec;275(3):1527-34. J Pharmacol Exp Ther. 1995. PMID: 8531125

10

Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.

Lin JH, Chiba M, Balani SK, Chen IW, Kwei GY, Vastag KJ, Nishime JA. Lin JH, et al. Among authors: nishime ja. Drug Metab Dispos. 1996 Oct;24(10):1111-20. Drug Metab Dispos. 1996. PMID: 8894513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results